The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
February 7th 2025
Investigators in Korea developed and validated PSED-FA, a reliable tool to assess parental confidence in managing children's food allergies and nutrition.
All Doses of Birch Pollen Allergoids Shown to be Safe for Allergic Rhinoconjunctivitis
This represented the first in human research focused on assessing the best dosing regimen of mannan-conjugated birch pollen allergoids for those with birch pollen–induced allergic rhinoconjunctivitis.
Dupilumab Prescriptions for Pediatric EoE Burdened by Prior Authorizations, Delayed Initiation
October 5th 2023An institution's review of prescriptions in the first year since dupilumab's historic FDA approval for eosinopihlic esophagitis shows patients waited a mean 46 days to initiate the biologic therapy.
Where There is Smoke: Wildfire Preparedness as a Health Care Provider
Amid the escalating threat of wildfires due to climate change, the medical and public health communities face an increasing responsibility to develop robust emergency response plans to safeguard patients and healthcare infrastructure.
Edwin H. Kim, MD: Thoughts on Intranasal Epinephrine Spray as an Alternative to EpiPen
In a new interview with the HCPLive editorial team, Edwin H. Kim, MD, spoke about the new ARS-1 (Neffy) intranasal epinephrine spray for patients having Type 1 allergic reactions as well as the FDA's upcoming decision on the treatment.
Hospitalizations Associated with Rotavirus Linked to Subsequent Autoimmune Disease in Childhood
This recent research indicates the necessity for clinicians to be aware of the higher autoimmune disease susceptibility of those with previous rotavirus-associated hospitalization.